Abstract
638 Splice-switching antisense oligonucleotides for the treatment of class I cystic fibrosis transmembrane conductance regulator mutations
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
